Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Franklin Genomic Advancements Fund W (acc) USD Fonds 113722507 / LU2387455947

5.93 USD
0.19 USD
3.31 %
21.1.2025
NAV

Nettoinventarwert (NAV)

5.93 USD 0.19 USD 3.31 %
Vortag 5.74 USD Datum 21.01.2025

Franklin Genomic Advancements Fund W (acc) USD Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 467.45%
21Shares Stellar ETP CH1109575535 353.23%
21Shares Algorand ETP CH1146882316 234.18%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Cardano ETP CH1102728750 176.17%
21Shares Sui Staking ETP CH1360612159 104.25%
21Shares Injective Staking ETP CH1360612134 -0.09%
21Shares Immutable ETP CH1360612142 -24.37%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 443.78%
21Shares Sui Staking ETP CH1360612159 423.12%
21Shares Stellar ETP CH1109575535 316.34%
21Shares Aave ETP CH1135202120 255.35%
21Shares Algorand ETP CH1146882316 166.93%
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Injective Staking ETP CH1360612134 -17.40%
21Shares Immutable ETP CH1360612142 -24.62%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 465.18%
21Shares Stellar ETP CH1109575535 279.67%
21Shares Aave ETP CH1135202120 266.61%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 227.82%
21Shares Solana staking ETP CH1114873776 170.26%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’066.11%
21Shares Ripple XRP ETP CH0454664043 657.73%
21Shares Stellar ETP CH1109575535 392.71%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 392.50%
21Shares Bitcoin Core ETP CH1199067674 389.08%

Fundamentaldaten

Valor 113722507
ISIN LU2387455947
Emittent Franklin Templeton International Services
Aufgelegt in Luxembourg
Auflagedatum 15.10.2021
Kategorie Branchen: Gesundheitswesen
Währung USD
Volumen 3’011’165.14
Depotbank J.P. Morgan SE, Luxembourg Branch
Geschäftsjahresende 30.06.
Berichtsstand 22.01.2025

Anlagepolitik

So investiert der Franklin Genomic Advancements Fund W (acc) USD Fonds: The Fund's investment objective is capital appreciation. The Fund invests principally in equity securities of companies that are relevant to the Fund’s investment theme of genomic advancements. Equity securities generally entitle the holder to participate in a company's general operating results. While the Fund invests predominantly in common stocks, it could also invest in preferred stock, convertible securities and warrants on securities.

ETP Performance: Franklin Genomic Advancements Fund W (acc) USD Fonds

Performance 1 Jahr
-2.38
Performance 2 Jahre
-8.01
Performance 3 Jahre
-25.36
Performance 5 Jahre -
Performance 10 Jahre -